302440 — SK Bioscience Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapFalling Star

Annual balance sheet for SK Bioscience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	94,469	208,708	1,645,663	1,475,506	1,268,841
Net Total Accounts Receivable
Net Total Receivables	32,429	54,008	48,135	89,661	22,342
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	170,741	333,902	1,837,804	1,783,694	1,382,969
Net Property, Plant And Equipment	190,770	189,479	220,983	293,057	315,923
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	403,980	562,232	2,110,123	2,141,931	1,852,439
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	45,509	180,639	459,952	380,037	135,620
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	171,246	298,442	508,811	400,229	148,584
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	232,734	263,790	1,601,312	1,741,702	1,703,855
Total Liabilities & Shareholders' Equity	403,980	562,232	2,110,123	2,141,931	1,852,439
Total Common Shares Outstanding